HBx induces hepatocellular carcinogenesis through ARRB1-mediated autophagy to drive the G₁/S cycle

References

• Xu QG, Yuan SX, Tao QF, et al. A novel HBx genotype serves as a preoperative predictor and fails to activate the JAK1/STATs pathway in hepatocellular carcinoma. J Hepatol. 2019;70:904–917.
   PubMed Web of Science ®Google Scholar
• Chan C, Thurnherr T, Wang J, et al. Global re-wiring of p53 transcription regulation by the hepatitis B virus X protein. Mol Oncol. 2016;10:1183–1195.
   PubMed Web of Science ®Google Scholar
• Wang J, Li N, Huang ZB, et al. HBx regulates transcription factor PAX8 stabilization to promote the progression of hepatocellular carcinoma. Oncogene. 2019;38:6696–6710.
   PubMed Web of Science ®Google Scholar
• Chen SL, Liu LL, Lu SX, et al. HBx-mediated decrease of AIM2 contributes to hepatocellular carcinoma metastasis. Mol Oncol. 2017;11:1225–1240.
   PubMed Web of Science ®Google Scholar
• Wang X, Li Y, Mao A, et al. Hepatitis B virus X protein suppresses virus-triggered IRF3 activation and IFN-beta induction by disrupting the VISA-associated complex. Cell Mol Immunol. 2010;7:341–348.
   PubMed Web of Science ®Google Scholar
• Fu L, Fu X, Mo J, et al. miR-146a-5p enhances hepatitis B virus replication through autophagy to promote aggravation of chronic hepatitis B. IUBMB Life. 2019;71:1336–1346.
   PubMed Web of Science ®Google Scholar
• Gao Q, Hou B, Yang H, et al. Distinct role of 4E-BP1 and S6K1 in regulating autophagy and hepatitis B virus (HBV) replication. Life Sci. 2019;220:1–7.
   PubMed Web of Science ®Google Scholar
• Wang K. Autophagy and apoptosis in liver injury. Cell Cycle. 2015;14:1631–1642.
   PubMed Web of Science ®Google Scholar
• Kunanopparat A, Kimkong I, Palaga T, et al. Increased ATG5-ATG12 in hepatitis B virus-associated hepatocellular carcinoma and their role in apoptosis. World J Gastroenterol. 2016;22:8361–8374.
   PubMed Web of Science ®Google Scholar
• Peantum J, Kunanopparat A, Hirankarn N, et al. Autophagy related-protein 16-1 Up-regulated in hepatitis B virus-related hepatocellular carcinoma and impaired apoptosis. Gastroenterology Res. 2018;11:404–410.
   PubMed Web of Science ®Google Scholar
• Wang P, Guo QS, Wang ZW, et al. HBx induces HepG-2 cells autophagy through PI3K/Akt-mTOR pathway. Mol Cell Biochem. 2013;372:161–168.
   PubMed Web of Science ®Google Scholar
• Tang H, Da L, Mao Y, et al. Hepatitis B virus X protein sensitizes cells to starvation-induced autophagy via up-regulation of beclin 1 expression. Hepatology. 2009;49:60–71.
   PubMed Web of Science ®Google Scholar
• Fu S, Wang J, Hu X, et al. Crosstalk between hepatitis B virus X and high-mobility group box 1 facilitates autophagy in hepatocytes. Mol Oncol. 2018;12:322–338.
   PubMed Web of Science ®Google Scholar
• Yue Z, Jin S, Yang C, et al. Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor. Proc Natl Acad Sci U S A. 2003;100:15077–15082.
   PubMed Web of Science ®Google Scholar
• Siddharth S, Muniraj N, Saxena NK, et al. Concomitant Inhibition of cytoprotective autophagy augments the efficacy of withaferin A in hepatocellular carcinoma. Cancers (Basel). 2019;11:453.
   Web of Science ®Google Scholar
• Kowalik MA, Perra A, Ledda-Columbano GM, et al. Induction of autophagy promotes the growth of early preneoplastic rat liver nodules. Oncotarget. 2016;7:5788–5799.
   PubMedGoogle Scholar
• Smith JS, Rajagopal S. The beta-arrestins: multifunctional regulators of G protein-coupled receptors. J Biol Chem. 2016;291:8969–8977.
   PubMed Web of Science ®Google Scholar
• Rosano L, Cianfrocca R, Tocci P, et al. Endothelin A receptor/beta-arrestin signaling to the Wnt pathway renders ovarian cancer cells resistant to chemotherapy. Cancer Res. 2014;74:7453–7464.
   PubMed Web of Science ®Google Scholar
• Kumari P, Srivastava A, Ghosh E, et al. Core engagement with beta-arrestin is dispensable for agonist-induced vasopressin receptor endocytosis and ERK activation. Mol Biol Cell. 2017;28:1003–1010.
   PubMed Web of Science ®Google Scholar
• Yang Y, Guo Y, Tan S, et al. Beta-Arrestin1 enhances hepatocellular carcinogenesis through inflammation-mediated Akt signalling. Nat Commun. 2015;6:7369.
   PubMed Web of Science ®Google Scholar
• Wang P, Xu TY, Wei K, et al. ARRB1/beta-arrestin-1 mediates neuroprotection through coordination of BECN1-dependent autophagy in cerebral ischemia. Autophagy. 2014;10:1535–1548.
   PubMed Web of Science ®Google Scholar
• Tan S, Lu Y, Xu M, et al. beta-Arrestin1 enhances liver fibrosis through autophagy-mediated Snail signaling. FASEB J. 2019;33:2000–2016.
   PubMed Web of Science ®Google Scholar
• Benn J, Schneider RJ. Hepatitis B virus HBx protein deregulates cell cycle checkpoint controls. Proc Natl Acad Sci U S A. 1995;92:11215–11219.
   PubMed Web of Science ®Google Scholar
• Koike K, Moriya K, Yotsuyanagi H, et al. Induction of cell cycle progression by hepatitis B virus HBx gene expression in quiescent mouse fibroblasts. J Clin Invest. 1994;94:44–49.
   PubMed Web of Science ®Google Scholar
• Zhang YX, Li XF, Yuan GQ, et al. beta-Arrestin 1 has an essential role in neurokinin-1 receptor-mediated glioblastoma cell proliferation and G2/M phase transition. J Biol Chem. 2017;292:8933–8947.
   PubMed Web of Science ®Google Scholar
• Li H, Peng X, Wang Y, et al. Atg5-mediated autophagy deficiency in proximal tubules promotes cell cycle G2/M arrest and renal fibrosis. Autophagy. 2016;12:1472–1486.
   PubMed Web of Science ®Google Scholar
• Azzopardi M, Farrugia G, Balzan R. Cell-cycle involvement in autophagy and apoptosis in yeast. Mech Ageing Dev. 2017;161:211–224.
   PubMed Web of Science ®Google Scholar
• Yu DY, Moon HB, Son JK, et al. Incidence of hepatocellular carcinoma in transgenic mice expressing the hepatitis B virus X-protein. J Hepatol. 1999;31:123–132.
   PubMed Web of Science ®Google Scholar
• Shin GC, Kang HS, Lee AR, et al. Hepatitis B virus-triggered autophagy targets TNFRSF10B/death receptor 5 for degradation to limit TNFSF10/TRAIL response. Autophagy. 2016;12:2451–2466.
   PubMed Web of Science ®Google Scholar
• Kreis NN, Louwen F, Yuan J. The multifaceted p21 (Cip1/Waf1/CDKN1A) in cell differentiation, migration and cancer therapy. Cancers (Basel). 2019;11:1220.
   Web of Science ®Google Scholar
• Ma L, Pei G. Beta-arrestin signaling and regulation of transcription. J Cell Sci. 2007;120:213–218.
   PubMed Web of Science ®Google Scholar
• Lloyd RV, Erickson LA, Jin L, et al. p27kip1: a multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers. Am J Pathol. 1999;154:313–323.
   PubMed Web of Science ®Google Scholar
• Fang G, Zhang P, Liu J, et al. Inhibition of GSK-3beta activity suppresses HCC malignant phenotype by inhibiting glycolysis via activating AMPK/mTOR signaling. Cancer Lett. 2019;463:11–26.
   PubMed Web of Science ®Google Scholar
• Lin X, Yang Y, Guo Y, et al. PTTG1 is involved in TNF-alpha-related hepatocellular carcinoma via the induction of c-myc. Cancer Med. 2019;8:5702–5715.
   PubMedGoogle Scholar
• Whalen EJ, Rajagopal S, Lefkowitz RJ. Therapeutic potential of beta-arrestin- and G protein-biased agonists. Trends Mol Med. 2011;17:126–139.
   PubMed Web of Science ®Google Scholar
• Duan L, Wu R, Zhang X, et al. HBx-induced S100A9 in NF-kappaB dependent manner promotes growth and metastasis of hepatocellular carcinoma cells. Cell Death Dis. 2018;9:629.
   PubMed Web of Science ®Google Scholar
• Tse AP, Sze KM, Shea QT, et al. Hepatitis transactivator protein X promotes extracellular matrix modification through HIF/LOX pathway in liver cancer. Oncogenesis. 2018;7:44.
   PubMed Web of Science ®Google Scholar
• Sung WK, Lu Y, Lee CW, et al. Deregulated direct targets of the hepatitis B virus (HBV) protein, HBx, identified through chromatin immunoprecipitation and expression microarray profiling. J Biol Chem. 2009;284:21941–21954.
   PubMed Web of Science ®Google Scholar
• Zhang HT, Chen GG, Hu BG, et al. Hepatitis B virus x protein induces autophagy via activating death-associated protein kinase. J Viral Hepat. 2014;21:642–649.
   PubMed Web of Science ®Google Scholar
• Liu J, Li QX, Wang XJ, et al. beta-Arrestins promote podocyte injury by inhibition of autophagy in diabetic nephropathy. Cell Death Dis. 2016;7:e2183.
   PubMed Web of Science ®Google Scholar
• Luan B, Zhao J, Wu H, et al. Deficiency of a beta-arrestin-2 signal complex contributes to insulin resistance. Nature. 2009;457:1146–1149.
   PubMed Web of Science ®Google Scholar
• Qu X, Yu J, Bhagat G, et al. Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. J Clin Invest. 2003;112:1809–1820.
   PubMed Web of Science ®Google Scholar
• Xie M, Yang Z, Liu Y, et al. The role of HBV-induced autophagy in HBV replication and HBV related-HCC. Life Sci. 2018;205:107–112.
   PubMed Web of Science ®Google Scholar
• Zhong F, Bi R, Yu B, et al. Carcinoma arising in microglandular adenosis of the breast: triple negative phenotype with variable morphology. Int J Clin Exp Pathol. 2014;7:6149–6156.
   PubMed Web of Science ®Google Scholar
• Jia W, He MX, McLeod IX, et al. Autophagy regulates T lymphocyte proliferation through selective degradation of the cell-cycle inhibitor CDKN1B/p27Kip1. Autophagy. 2015;11:2335–2345.
   PubMed Web of Science ®Google Scholar
• Jiang H, Martin V, Gomez-Manzano C, et al. The RB-E2F1 pathway regulates autophagy. Cancer Res. 2010;70:7882–7893.
   PubMed Web of Science ®Google Scholar
• Dai Y, Cros MP, Pontoizeau C, et al. Downregulation of transcription factor E4F1 in hepatocarcinoma cells: HBV-dependent effects on autophagy, proliferation and metabolism. Carcinogenesis. 2014;35:635–650.
   PubMed Web of Science ®Google Scholar
• Ruan C, Wang C, Gong X, et al. An integrative multi-omics approach uncovers the regulatory role of CDK7 and CDK4 in autophagy activation induced by silica nanoparticles. Autophagy. 2020:1–22. DOI:https://doi.org/10.1080/15548627.2020.1763019
   Google Scholar
• Chandrashekar DS, Bashel B, Balasubramanya SAH, et al. UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses. Neoplasia. 2017;19:649–658.
   PubMed Web of Science ®Google Scholar
• Yeo W, Chan SL, Mo FK, et al. Phase I/II study of temsirolimus for patients with unresectable hepatocellular carcinoma (HCC)- a correlative study to explore potential biomarkers for response. BMC Cancer. 2015;15:395.
   PubMed Web of Science ®Google Scholar